28
March
2024
SMITH & NEPHEW
PLC
Notification under Listing Rule
9.6.12
Further to the announcement made on
2 November 2023, Smith+Nephew (LSE: SN, NYSE: SNN), the global
medical technology business,
announces that John
Rogers will join the Board as an Executive
Director and Chief Financial Officer on 1 April 2024, succeeding
Anne-Francoise Nesmes whose last day on the Board will be 31 March
2024.
Further disclosures regarding
confirmation of Anne-Françoise's departure
including in relation to remuneration will
be made in due course in accordance with applicable legislation,
including in the Directors' Remuneration Report for the relevant
year.
Enquiries
Investors / Analysts
Katharine Rycroft
Smith+Nephew
|
+44 (0) 1923 477433
|
Media
Charles Reynolds
Smith+Nephew
|
+44 (0) 1923 477314
|
Susan Gilchrist / Ayesha Bharmal
Brunswick
|
+44 (0) 20 7404 5959
|
About Smith+Nephew
Smith+Nephew is a portfolio medical
technology business that exists to restore people's bodies and
their self-belief by using technology to take the limits off
living. We call this purpose 'Life Unlimited'. Our 19,000 employees
deliver this mission every day, making a difference to
patients' lives through the excellence of our product
portfolio, and the invention and application of new technologies
across our three global business units of Orthopaedics,
Advanced Wound Management and Sports Medicine & ENT.
Founded in Hull, UK, in 1856, we now
operate in more than 100 countries, and generated annual sales of
$5.2 billion in 2022. Smith+Nephew is a constituent of the FTSE100
(LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used
to refer to Smith & Nephew plc and its consolidated
subsidiaries, unless the context requires otherwise.
For more information about
Smith+Nephew, please visit www.smith-nephew.com and
follow us on X, LinkedIn, Instagram or Facebook.
Forward-looking Statements
This document may contain forward-looking statements that may
or may not prove accurate. For example, statements regarding
expected revenue growth and trading profit margins, market trends
and our product pipeline are forward-looking statements. Phrases
such as "aim", "plan", "intend", "anticipate", "well-placed",
"believe", "estimate", "expect", "target", "consider" and similar
expressions are generally intended to identify forward-looking
statements. Forward-looking statements involve known and unknown
risks, uncertainties and other important factors that could cause
actual results to differ materially from what is expressed or
implied by the statements. For Smith+Nephew, these factors include:
risks related to the impact of Covid, such as the depth and
longevity of its impact, government actions and other restrictive
measures taken in response, material delays and cancellations of
elective procedures, reduced procedure capacity at medical
facilities, restricted access for sales representatives to medical
facilities, or our ability to execute business continuity plans as
a result of Covid; economic and financial conditions in the markets
we serve, especially those affecting healthcare providers, payers
and customers (including, without limitation, as a result of
Covid); price levels for established and innovative medical
devices; developments in medical technology; regulatory approvals,
reimbursement decisions or other government actions; product
defects or recalls or other problems with quality management
systems or failure to comply with related regulations; litigation
relating to patent or other claims; legal and financial compliance
risks and related investigative, remedial or enforcement actions;
disruption to our supply chain or operations or those of our
suppliers (including, without limitation, as a result of Covid);
competition for qualified personnel; strategic actions, including
acquisitions and dispositions, our success in performing due
diligence, valuing and integrating acquired businesses; disruption
that may result from transactions or other changes we make in our
business plans or organisation to adapt to market developments;
relationships with healthcare professionals; reliance on
information technology and cybersecurity; disruptions due to
natural disasters, weather and climate change related events;
changes in customer and other stakeholder sustainability
expectations; changes in taxation regulations; effects of foreign
exchange volatility; and numerous other matters that affect us or
our markets, including those of a political, economic, business,
competitive or reputational nature. Please refer to the documents
that Smith+Nephew has filed with the U.S. Securities and Exchange
Commission under the U.S. Securities Exchange Act of 1934, as
amended, including Smith+Nephew's most recent annual report on Form
20-F, which is available on the SEC's website at www.
sec.gov, for a discussion of certain of these factors. Any
forward-looking statement is based on information available to
Smith+Nephew as of the date of the statement. All written or oral
forward-looking statements attributable to Smith+Nephew are
qualified by this caution. Smith+Nephew does not undertake any
obligation to update or revise any forward-looking statement to
reflect any change in circumstances or in Smith+Nephew's
expectations.
◊ Trademark of Smith+Nephew.
Certain marks registered in US Patent and Trademark
Office.